ScholarIQanswers from OpenAlex

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

PaperCitations, authors & open-access status

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma have?

ScholarIQcitation count

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma has 1,961 citations in the OpenAlex counts ScholarIQ stores.

When was Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma published?

ScholarIQyear

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma has 2018 year in the ScholarIQ index.

What is the open-access status of Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma?

ScholarIQoa status

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma has bronze oa status in the ScholarIQ index.

What is the DOI of Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma?

ScholarIQdoi

The DOI for Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma is on the source record.

What is the PMID of Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma?

ScholarIQpmid

The PMID for Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma is on the source record.

What is the OpenAlex record for Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma?

ScholarIQopenalex

The OpenAlex for Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial